A Phase I Randomized, Observer-Blinded, Dose-Ranging Study in Healthy Subjects 24 to <72 Months of Age

Clinical trial NCT02296463 · COMPLETED

Trial details

NCT number: NCT02296463
Sponsor: Novavax
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Respiratory Synctial Virus

Start date: 2014-11-01
Primary completion: 2015-09-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.